Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: kahunabear who wrote (48442)	2/24/1999 12:23:00 AM
From: Knighty Tin	Respond to of 132070

WS, I know G(i)zmo, don't know ENMD in any detail. I like Gizmo, but they are many moons away from making any money. They are a one trick pony and will require a lot of funding. That being said, they have a lot of funding, protein biotech has been by far the most successful branch of biotech (the best stuff from Amgen, Biogen, Genentech and Genzyme, for example) up to now, and it is exciting to see a new focus in the area. Genzyme is not a bunch of mugs. Every product they have brought past Phase II is on the market. Sadly, the ones I own shares in are still selling at a loss. <g> But they are selling and are working. I am a buyer under $4. MB